Medicalia.org

by Internet Medical Society

Etanercept: A white crystalline non-hygroscopic solid

The FDA approved the drug Etanercept in 2012 to treat patients with moderately to severely active rheumatoid arthritis (RA), moderately to severely active polyarticular juvenile idiopathic arthritis (JIA), psoriatic arthritis (PsA), active ankylosing spondylitis (AS) and chronic moderate to severe plaque psoriasis (PsO). Etanercept is the active ingredient composed of inactive ingredients L-arginine hydrochloride, sodium chloride, and sucrose in the vials. The single-dose vials of Etanercept come in 25 mg and 50 mg to administer subcutaneously. Etanercept 25 mg and 50 mg vials are readily available from licensed generic medicine suppliers.

Views: 1

Comment

You need to be a member of Medicalia.org to add comments!

Join Medicalia.org

Advertisement

Interested in advertising on Medicalia.org?

-------------------------

-------------------------

-------------------------

INTERNATIONAL ARCHIVES OF MEDICINE

Submit your manuscript

© 2022   Created by Network Admin.   Powered by

Badges  |  Report an Issue  |  Terms of Service